Siriraj Faculty Abroad at the “ESTRO 2024” in the UK

From May 3^rd – 7^th, 2024, Dr. Tissana Prasartseree, MD, a Clinical Educator from the Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, presented an oral presentation on the topic “CT- and MRI-based Bone Marrow Dose in CCRT for Cervical Cancer: A Pooled Data from 2 Prospective trials” at The European Society for Radiotherapy and Oncology (ESTRO) 2024 in Glasgow, United Kingdom. Dr. Prasartseree aims to publish this research and establish a new standard in radiotherapy planning for cervical cancer, integrating bone marrow dose constraints.

ESTRO 2024, themed “Radiation Oncology: Bridging the Care Gap”, aims to strengthen radiation oncology’s role as a vital partner in multidisciplinary cancer care. The society’s vision for 2030, “Radiation Oncology. Optimal Health for All, Together”, underscores its commitment to providing accessible, high-value radiation therapy for all cancer patients. The conference will feature Europe’s largest industry exhibition in radiation oncology, offering unparalleled opportunities to engage with industry leaders and explore cutting-edge advancements in technology, techniques, and oncology products.